This literature review explores the plausibility of a sometimes-observed association between neuropathic pain and statin use. |
Statins are complex drugs that work to lower cholesterol by reversibly inhibiting enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and they likewise reduce C-reactive protein levels and may decrease the levels of pro-inflammatory cytokines. |
Neuropathic pain occurs in 1.5% to 6.9% of the general population and is particularly prevalent among people with type 2 diabetes. |
In animal studies, statins appear to reduce neuropathic pain but in humans, lowered cholesterol has been observed in association with increased neuropathic pain. |
Impaired mitochondrial transport has been implicated as playing a role in the development of neuropathy and is associated with deficits in vitamin E. |
Statins can inhibit the synthesis of ubiquinone (co-enzyme Q) and it is not yet elucidated if this may be associated with neuropathy. |
The American Heart Association has stated that there is “no convincing evidence for a causal relationship” between statins and peripheral neuropathy although such observations persist in medicine |
Statins are pleiotropic drugs and are associated with many effects, of which only a subset has been elucidated, but there is no clear link between statins and neuropathic pain. |
Introduction
Type | Example(s) | Comments |
---|---|---|
Iatrogenic | Chemotherapy-induced peripheral neuropathy | May resolve when chemotherapy ends |
Disease-related | Diabetic polyneuropathy; neuropathy related to leprosy | Neuropathy may also occur with critical illness |
Toxic | Neuropathy caused by lead poisoning, arsenic, ethanol, etc. | Includes alcohol-associated neuropathic syndromes |
Inflammatory | Vasculitis; chronic inflammatory demyelinating polyradiculopathy | Some of these conditions are heritable Inflammatory neuropathy may also occur following surgery |
Nutritional | Nutritional deficits | Nutritional interventions are sometimes recommended for this and diabetic neuropathy |
Specific types | Gullain–Barre syndrome; ataxic neuropathy | Numerous other neurological disorders may result in neuropathic pain syndromes |
Methods
Results
Diabetic Neuropathy
Neuropathy Not Associated with Diabetes
The Paradox of Statins and Neuropathic Pain
Study | Neuropathy induction | Drugs | Tests | Results | Conclusions |
---|---|---|---|---|---|
Ciric 2018 | High-fat diet to induce type 2 diabetes and metabolic syndrome | Metformin and simvastatin | Ultrastructural characteristics of sciatic nerve fibers | Structural defects in myelin sheath found and increased with metformin used but decreased with simvastatin | Simvastatin appeared to have beneficial effects on myelin structure of the sciatic nerve in this model |
Corso 2018 | Sciatic nerve crush | Simvastatin 20 and 80 mg/kg or morphine 1 h before 2.5% formalin injection | Mechanical pain; Cold allodynia; Nerve function | Simvastatin (2 and 80 mg/kg) reduce inflammatory pain caused by formalin but did not reduce edema in the paw; Simvastatin showed neuroprotective effects | Oral simvastatin reduced pain and inflammation; both lower and higher doses effective |
Jabeen 2011 | Obese rats, some fed high-fat diet, others a normal diet | Simvastatin | Conduction velocity of sciatic nerve | Obese rats had decreased nerve conduction velocity vs. controls; Conduction velocity was improved in all rats by simvastatin | Simvastatin improved sciatic nerve conduction in obese and lean animals and this improvement could be enhanced with co-administration of alpha-tocopherol |
Ii 2005 | Type 2 diabetes | Rosuvastatin | Sciatic nerve conduction velocity; Tail-flick test; Sciatic nerve collection | Rosuvastatin reduced pain, inhibited downregulation of neuronal nitric oxide synthase | Rosuvastatin had beneficial effect on diabetic neuropathy independent of its cholesterol-reducing effects |
Li 2018 | L5 spinal nerve transection | Rosuvastatin; morphine | Spinal cord collection | Five days of rosuvastatin restored nociception by morphine significantly and inhibited IL-1β | Rosuvastatin is effective in treating neuropathic pain |
Miranda 2018 Murine | Paclitaxel Partial sciatic nerve ligation | Rosuvastatin | Cold plate Hot plate Von Frey assays Changes in spinal cord levels of IL-1β | Paclitaxel and partial sciatic nerve ligation induced peripheral neuropathy in 7–14 days Rosuvastatin induced a dose-dependent antinociception with all three tests and increased IL-1β and glutathione were reduced by rosuvastatin | Rosuvastatin was effective in reducing neuropathic pain in this model |
Pathak 2014 | Chronic constriction injury | Atorvastatin | Pain behaviors; markers for oxidative stress in sciatic nerve | Oxidative stress on sciatic nerve was inhibited | Atorvastatin attenuated neuropathic pain |